349 results
8-K
EX-99.1
LCTX
Lineage Cell Therapeutics, Inc.
8 Aug 24
Lineage Cell Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
4:10pm
Purchase of equipment
Net cash (used in) provided by investing activities
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from employee options exercised …
Common shares received and retired for employee taxes paid
Proceeds from sale of common shares
Payments for offering costs
Repayment of finance lease
8-K
EX-3.1
LCTX
Lineage Cell Therapeutics, Inc.
13 Jun 24
Amendments to Articles of Incorporation or Bylaws
4:30pm
capacity (including as an officer, agent, employee, or otherwise) and receiving compensation for those services.
Section 14.Section 14. Removal of Directors … , employee, or other agent of the Corporation, or is or was serving at the request of the Corporation as a director, officer, employee, or agent of another
8-K
EX-3.1
LCTX
Lineage Cell Therapeutics, Inc.
13 Jun 24
Amendments to Articles of Incorporation or Bylaws
4:30pm
(including as an officer, agent, employee, or otherwise) and receiving compensation for those services.
Section 14.Removal of Directors. The entire … . For the purposes of this Article VI, “agent” means any person who is or was a director, officer, employee, or other agent of the Corporation
8-K
EX-99.1
iitj01mej5wpagq6
9 May 24
Lineage Cell Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
4:10pm
8-K
EX-1.1
qhns10615mso
22 Mar 24
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-99.1
owcbn3dww xfk
7 Mar 24
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
4:10pm
8-K
EX-10.1
wjp2akgl
6 Feb 24
Lineage Cell Therapeutics Announces $14.0 Million Registered Direct Offering
9:20am
S-8
c576 hzz94tkj
13 Nov 23
Registration of securities for employees
4:19pm
8-K
EX-99.1
5vks1w co408
9 Nov 23
Lineage Cell Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
4:10pm